<DOC>
	<DOC>NCT00933673</DOC>
	<brief_summary>The purpose of this study is to evaluate the efficacy and tolerability of the combination chemotherapy of L-asparaginase plus DICE regimen in the patients with early stage NK/T-cell lymphoma.</brief_summary>
	<brief_title>New Combination Regimen of L-asparaginase, Dexamethasone, Ifosfamide, Cisplatin and Etoposide in NK/T-Cell Lymphoma</brief_title>
	<detailed_description>DICE regimen was found to be highly effective as induction chemotherapy in patients with early stage NK/T-cell lymphoma in the ongoing study. L-asparaginase, an agent with unique anti-cancer mechanism, was also found to be effective in salvage setting. In terms of non-overlapped efficacy and toxicity, the investigators designed this phase II study to verify the efficacy and tolerability of this new combination.</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma, T-Cell</mesh_term>
	<mesh_term>Asparaginase</mesh_term>
	<criteria>Age range 1475 years old Histological confirmed, previously untreated stage I/II NK/T cell lymphoma in the upperaerodigestive tract ECOG performance status less than 2 Life expectancy of more than 3 months Normal laboratory values: hemoglobin &gt; 80 g/dl, neutrophil &gt; 2×109/L, platelet &gt; 100×109/L, serum creatine &lt; 1.5×upper limitation of normal (ULN), serum bilirubin &lt; 1.5×ULN, ALT and AST &lt; 2.5×ULN Pregnant or lactating women Serious uncontrolled diseases and intercurrent infection The evidence of CNS metastasis History of other malignancies except cured basal cell carcinoma of skin and carcinoma insitu of uterine cervix</criteria>
	<gender>All</gender>
	<minimum_age>14 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>NK/T cell lymphoma</keyword>
	<keyword>DICE</keyword>
	<keyword>L-asparaginase</keyword>
</DOC>